BG
Bellevue Group Portfolio holdings
AUM
$5.28B
1-Year Est. Return
50.12%
This Fund
S&P 500
1 Year Est. Return
+50.12%
AUM
$5.28B
AUM Growth
+$464M
(+9.6%)
Holding
185
Top Buys
| 1 | +$120M | |
| 2 | +$105M | |
| 3 | +$102M | |
| 4 |
Krystal Biotech
KRYS
|
+$86.1M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$75.6M |
Top Sells
| 1 | +$149M | |
| 2 | +$139M | |
| 3 | +$113M | |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$109M |
| 5 |
argenx
ARGX
|
+$72.3M |
Sector Composition
| 1 | Healthcare | 99.71% |
| 2 | Technology | 0.1% |
| 3 | Consumer Discretionary | 0.05% |
| 4 | Financials | 0.03% |
| 5 | Communication Services | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
HCA Healthcare
HCA
$118B
| $20.5M | 0.39% |
43,906
-21,701
|
|
||
52
Humana
HUM
$22.1B
| $18.7M | 0.35% |
73,081
-3,229
|
|
||
53
Veeva Systems
VEEV
$29.3B
| $18M | 0.34% |
80,529
-16,977
|
|
||
54
Procept Biorobotics
PRCT
$1.4B
| $16.2M | 0.31% |
515,430
+52,026
|
|
||
55
Natera
NTRA
$27.3B
| $12.8M | 0.24% |
56,036
-35,782
|
|
||
56
Masimo
MASI
$9.42B
| $12.7M | 0.24% |
97,285
+317
|
|
||
57
Transmedics
TMDX
$4.84B
| $11.9M | 0.23% |
97,885
-19,083
|
|
||
58
Centene
CNC
$21.6B
| $11.3M | 0.21% |
273,674
-8,275
|
|
||
59
Regeneron Pharmaceuticals
REGN
$83.7B
| $10.8M | 0.2% |
13,928
-1,129
|
|
||
60
Privia Health
PRVA
$2.91B
| $10.6M | 0.2% |
448,163
-218,014
|
|
||
61
Teva Pharmaceuticals
TEVA
$38B
| $10.2M | 0.19% |
327,863
-96,193
|
|
||
62
Structure Therapeutics
GPCR
$4.38B
| $10.1M | 0.19% |
145,167
-170,690
|
|
||
63
Merck
MRK
$296B
| $9.7M | 0.18% |
92,117
+57,378
|
|
||
64
IQVIA
IQV
$29.1B
| $9.3M | 0.18% |
41,267
-11,631
|
|
||
65
Inspire Medical Systems
INSP
$1.81B
| $9.29M | 0.18% |
100,761
+42,113
|
|
||
66
CVS Health
CVS
$104B
| $8.65M | 0.16% |
109,058
+57,859
|
|
||
67
CareDx
CDNA
$934M
| $8.12M | 0.15% |
431,070
-141,886
|
|
||
68
Molina Healthcare
MOH
$7.71B
| $8.09M | 0.15% |
46,626
-44,359
|
|
||
69
Tenet Healthcare
THC
$20.2B
| $8M | 0.15% |
40,239
-133
|
|
||
|
WAY
70
Waystar Holding Corp
WAY
$4.96B
| $7.92M | 0.15% |
241,734
+111,821
|
|
||
71
Gilead Sciences
GILD
$184B
| $6.47M | 0.12% |
52,752
+2,859
|
|
||
72
Amgen
AMGN
$205B
| $6.05M | 0.11% |
18,489
+3,501
|
|
||
73
10x Genomics
TXG
$2.76B
| $5.25M | 0.1% |
322,060
+8,224
|
|
||
74
Ascendis Pharma
ASND
$14.5B
| $5.19M | 0.1% |
24,330
-573
|
|
||
75
Axsome Therapeutics
AXSM
$8.47B
| $5.04M | 0.1% |
27,600
-24,735
|
|